# US 2006/0078496 A1 · Method of drug delivery to interstitial regions of the myocardium

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0078496 A1
- Document ID: US20060078496A1
- Status: Published application
- Kind: A1
- Application number: 11/231,100
- Filed: 2005-09-19
- Published: 2006-04-13
- Earliest claimed: 1997-03-13
- Assignees: BioCardia, Inc.
- Inventors: Peter Altman; K. Crockett
- Web page: https://patentgrep.com/patent/US20060078496A1

## CPC

- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61K 9/1676: {having a drug-free core with discrete complete coating layer containing drug (adsorbates of liquid drug formulations on inert powders without simultaneous granulation step A61K9/141; with further drug-free outer coating A61K9/5078; drug conjugated to non-active particles A61K47/6921)}
- A61K 9/50: Microcapsules {having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals (A61K9/2081 takes precedence; particles with a single coating comprising drug A61K9/167)}
- A61N 1/0575: {with drug delivery}
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/06: Antiarrhythmics
- A61P 9/08: Vasodilators for multiple indications
- A61B 2017/00247: {Making holes in the wall of the heart, e.g. laser Myocardial revascularization}
- A61B 2018/00011: {with fluids}
- A61B 2018/00351: {Heart}
- A61B 2018/00392: {Transmyocardial revascularisation}
- A61B 2018/00577: {Ablation}
- A61B 2018/00839: {Bioelectrical parameters, e.g. ECG, EEG}
- A61B 2018/1425: {Needle}
- A61B 2018/1435: {Spiral}
- A61B 2218/002: Irrigation
- A61K 9/5084: {Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs (tablets containing such a mixture A61K9/2077)}
- A61M 2025/0089: {Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A method of treating the heart and other body tissues by injecting a compound comprised of microsphere encapsulated macromolecule therapeutic agents into the myocardium, such that the microsphere size inhibits capillary transport of the compound but may permit lymphatic transport of the compound, and the compound releases therapeutic agents upon degradation of the microsphere. The compounds may be used in a method of treating the coronary arteries in which lymphatic transportable therapeutic agents are injected into the myocardium at a location distal to a target site in the coronary artery, after which they are taken up by the lymphatic vessels and transported proximally relative to the coronary artery, and migrate from the lymphatic vessel to the coronary blood vessel.

## Claims

### Claim 1

A composition for treatment of body tissue comprising:
a plurality of microspheres for treatment of body tissue, said microspheres being degradable in the body;
wherein said microspheres comprise an outer layer and an inner core inside the outer layer;
wherein the outer layer comprises an anti-angiogenic agent that can enter the lymphatic system of a heart in a first time period; and
wherein the inner core comprises an angiogenic agent that can only enter the lymphatic system of the heart in a second time period subsequent to the first time period.

### Claim 2 (depends on 1)

The composition of claim 1 wherein the microspheres have an initial diameter greater than 30 μm.

### Claim 3 (depends on 1)

The composition of claim 1 wherein the microspheres have an initial diameter between about 50 μm to about 600 μm.

### Claim 4

A composition for treatment of body tissue comprising:
a first group of microspheres sized to permit entry into the lymphatic system of the heart in a first time period; and
a second group of microspheres sized to inhibit entry into the lymphatic system of the heart in the first time period and permit entry into the lymphatic system of the hear in a subsequent time period
wherein the first group of microspheres comprises an anti-angiogenic agent and the second group of microspheres comprises an angiogenic agent
wherein the first group and second group of microspheres are degradable in the body.
